Table 2.
Selected Outcomes Following TURP for AUR Versus Symptoms Only
| Outcome | Relative (Risk 95 % CI) | AUR | Symptoms | Chi-Square |
|---|---|---|---|---|
| Intraoperative | 18 (CI 1.3–2.5) | 61 (5.0%) | 76 (2.9%) | <.001 |
| complications | ||||
| Bleeding | 26 (2.1%) | 33 (1.2%) | ||
| Transfusion > 2 units | 2.5 (CI 1.8–3.3) | 93 (7.7%) | 87 (3.3%) | <.001 |
| Return to OR | 2.5 (CI 1.8–3.3) | 39 (3.1%) | 38 (1.4%) | <.001 |
| Postoperative | 1.6 (CI 1.2–2.0) | 124 (10.2%) | 177 (6.8%) | <.001 |
| complications | ||||
| Postoperative | 2.1 (CI 1.8–2.4) | 605 (50.0%) | 845 (32.6%) | <.001 |
| antibiotics | ||||
| In-Hospital | 3.3 (CI 1.2–9.3) | 9 (0.7%) | 6 (0.2%) | .024 |
| mortality | ||||
| Mortality | 26.6 (CI 3.5–205) | 12 (1.0%) | 1 (< 0.1%) | <.001 |
| 30-day OPCS | ||||
| Mortality | 4.4 (CI 2.5–7.6) | 37 (3.0%) | 19 (0.7%) | <.001 |
| 90-day OPCS |
Data from Pickard et al.38
TURP, transurethral resection of the prostate; AUR, acute urinary retention; OR, operating room; OPCS, Office of Population Census and Surveys